Latest News
- Georgia Ban on Transgender Healthcare Challenged in Lawsuit
- Madrigal Opens Submission for NASH Drug Application With FDA
- Drugmaker Partners Launch Copycat for Arthritis Drug Humira
- Bausch + Lomb Buys Novartis Drugs for $1.75 Billion
- Indiana's Top Court Allows Near-Total Abortion Ban
- Medical Cannabis Does Not Reduce Use of Prescription Meds
- CV Benefit From Vitamin-D Caps Hinted in Huge D-Health Trial
- Race, Ethnicity Loom Large in CRC Screening
- Family Docs Provide Most Care for Several Chronic Diseases
- ADA 2023 COORDINATE-Diabetes: a 'Wake-Up Call' for Many Specialties
- Overdose Deaths, Gun Violence Steadily on the Rise
- Long COVID 'Brain Fog' Confounds Doctors, but New Research Offers Hope
- Do Oral Contraceptives Increase Depression Risk?
- IBD Study Characterizes Biologic Adherence
- ADA 2023 33% of Type 1 Diabetes Patients Insulin-Free With Stem Cells
- Worrying About Elections Is Unhealthy
- New Research Criteria May Help Predict Progression to CTE
- Lean Muscle Mass Protective Against Alzheimer's?
- AHS 2023 Children of Color Get Less Testing, Diagnosis of Migraine
- Study Evaluates Pregnancy Risks With Biologics for Psoriasis